CJC-1295 DAC
From $46.00
CJC-1295 with DAC is a modified synthetic analogue of growth hormone-releasing hormone (GHRH). It incorporates a Drug Affinity Complex designed to facilitate interaction with serum albumin, a feature investigated for its role in extending peptide circulation time.
The compound is studied in experimental research involving GHRH receptor pharmacology, endocrine signaling, and long-acting peptide design.
Research Applications
GHRH Receptor Research
CJC-1295 DAC is investigated for its interactions with growth hormone-releasing hormone receptors and associated intracellular signaling pathways.
Endocrine Signaling
Experimental studies examine the compounds activity within biological pathways related to pituitary hormone signaling.
Peptide Pharmacokinetics
The DAC modification is of interest in research exploring peptide stability, albumin binding, and extended circulation.
Long-Acting Peptide Engineering
Researchers investigate DAC-modified peptides to better understand molecular modifications that influence peptide distribution and persistence.
Pricing
- 5 mg: $46.00
Lot: 5002. View lot certificates.
For in-vitro laboratory research use only. Not for human or veterinary use.
FAQs
- Is CJC-1295 DAC for human use?
- No. La Rosa Labs materials are sold strictly for in-vitro laboratory research. They are not drugs, supplements, foods, or cosmetics.
- Can I review lot documentation before ordering?
- Yes. Lot details and certificates are published for review on the product page and lot certificates section before purchase.
- Do vial sets change the per-vial price?
- Yes. 3-vial and 5-vial sets reduce the per-vial price versus a single vial. Compare options on the product page before checkout.